Spelling suggestions: "subject:"trypanosoma ""
91 |
Characterisation of Trypanosomal Type III and Type IV Hsp40 proteinsLouw, Cassandra Alexandrovna January 2009 (has links)
The heat shock protein-70 (Hsp70) family of molecular chaperones are ubiquitous highly conserved proteins that are critical for the viability of cellular homeostasis. The ATPase activity of Hsp70 proteins is critical to their function as the affinity of a given Hsp70 for non-native substrate is modulated by ATP binding and hydrolysis. When bound to ATP, Hsp70s possess a low affinity for a given substrate protein, while the hydrolysis of ATP to ADP causes a conformational change that results in a high affinity for substrate proteins. The basal ATPase activity of Hsp70s is too low to facilitate their function in vivo, and co-chaperones are essential to modulate the efficient protein folding by Hsp70. Heat shock protein-40 (Hsp40) heat shock proteins are essential for the in vivo function of Hsp70s by stimulating the ATPase activity of these proteins and facilitating transfer of substrates. The Type III class of Hsp40 proteins have not been well characterised due to their poor levels of conservation at the primary sequence level. This is due to the fact that Type III Hsp40s only contain a J-domain and a poorly conserved C-terminal region. The newly identified Type IV class of Hsp40s, contain an abrogated HPD tripeptide motif in the J-domain and have also not been extensively studied. Trypanosoma brucei (T. brucei) is a unicellular flagellated protozoan parasite. It is the causative agent of Human African Trypansomiasis (HAT) which results in thousands of deaths and devastating agricultural losses in many parts of Africa. T. brucei undergoes a complex lifecycle that is characterised by the transition from an insect vector to a mammalian host in markedly different conditions of temperature, pH, nutrient availability and respiratory requirements. It has been proposed that molecular chaperones may enhance the survival of these parasites due to their cytoprotective effect in combating cellular stress. Due to the fact that T. brucei infection is invariably fatal if left untreated, and that no novel treatment regimens have been developed recently, the identification of potential novel drug targets among proteins essential to the parasite’s survival in the host organism is an attractive aspect of T. brucei research. Because Type III Hsp40s are poorly conserved with respect to Hsp40s found in the human host, the identification of any of these proteins found to be essential to T. brucei survival in humans could potentially make attractive novel drug targets. An in depth in silico investigation into the Type III Hsp40 complement as well as partner Hsp70 proteins in T.brucei was performed. T. brucei possesses 65 Hsp40 proteins, of which 47 were classed as Type III and 6 of which were identified as being putative Type IV Hsp40s. A small but significant number (5) of Type III TbHsp40s contained tetratricopeptide (TPR) domains in addition to the J-domain. The J-domains of the Type III TbHsp40 complement were found to be conserved with respect to those of canonical Hsp40 proteins, although the mutation of certain residues that play a key role in Hsp40-Hsp70 interaction was noted. Potential partnerships of these proteins in the parasite was also investigated. The coding regions of three previously uncharacterised TbHsp40s were successfully amplified from T. brucei TREU927 genomic DNA and cloned into an expression vector. Tbj1, a Tcj1 ortholog, was selected for further study and successfully expressed and biochemically characterised. Tbj1 expressed in E. coli was found to be insoluble, but large amounts were recovered with the aid of a denaturing purification followed by refolding elution strategies, and the bulk of the protein recovered was in compact monomeric form as determined by size-exclusion chromatography fast protein liquid chromatography (SEC-FPLC). The addition of Tbj1 to a thermally aggregated substrate resulted in increased levels of aggregation, although Tbj1 was able to assist two Hsp70 proteins in the suppression of aggregation. Tbj1 proved unable to stimulate the ATPase activity of these same Hsp70s, and could not rescue temperature sensitive cells when replacing E.coli DnaJ and CbpA. It was concluded that Tbj1 does not possess independent chaperone activity, but could display Hsp40 co-chaperone properties under certain circumstances. This could allude to a specialised function in the T. brucei parasite. The lack of human orthologues to Tbj1 could result in the attractiveness of this protein as a novel drug target.
|
92 |
The complement fixation test in the diagnosis of the rickettsial diseases of man tick borne relapsing fever, African human trypanosomiasis, and Rift valley feverWolstenholme, Brian 03 May 2017 (has links)
No description available.
|
93 |
Immunodiffusion and immunoelectrophoretic studies on Trypanosoma lewisi (Kent) during the course of an infection in the albino rat, Rattus rattusDrew, Carol Louise Perkins 01 January 1970 (has links)
Immunoelectrophoresis revealed an antigen-antibody response between 4 day metabolic products and 8, 12 and 16 day sera and between 4 day trypanosomal extract and 16 day serum.
Metabolic products from trypanosomes incubated at room temperature do not appear to be antigenic.
The limitations of immunodiffusion are discussed in reference to the results. It is suggested that some of the antibodies to metabolic products may be of the precipitating type while others are not.
Since a faint reaction also occurred between 4 day trypanosomal extract and 16 day serum, it may be concluded that metabolic products contribute to only a portion of the antibody response of the rat and are by no means the exclusive agents. They possibly work in conjunction with other metabolics within or on the surface of the trypanosome.
|
94 |
Development of a tissue-engineered primary human skin infection model to study the pathogenesis of tsetse fly-transmitted African trypanosomes in mammalian skin / Entwicklung eines primären humanen Hautinfektionsmodells basierend auf Gewebezüchtung zur Erforschung der Pathogenese von Tsetsefliegen-übertragenen Afrikanischen Trypanosomen in der SäugetierhautReuter, Christian Steffen January 2023 (has links) (PDF)
Many arthropods such as mosquitoes, ticks, bugs, and flies are vectors for the transmission of pathogenic parasites, bacteria, and viruses. Among these, the unicellular parasite Trypanosoma brucei (T. brucei) causes human and animal African trypanosomiases and is transmitted to the vertebrate host by the tsetse fly. In the fly, the parasite goes through a complex developmental cycle in the alimentary tract and salivary glands ending with the cellular differentiation into the metacyclic life cycle stage. An infection in the mammalian host begins when the fly takes a bloodmeal, thereby depositing the metacyclic form into the dermal skin layer. Within the dermis, the cell cycle-arrested metacyclic forms are activated, re-enter the cell cycle, and differentiate into proliferative trypanosomes, prior to dissemination throughout the host.
Although T. brucei has been studied for decades, very little is known about the early events in the skin prior to systemic dissemination. The precise timing and the mechanisms controlling differentiation of the parasite in the skin continue to be elusive, as does the characterization of the proliferative skin-residing trypanosomes. Understanding the first steps of an infection is crucial for developing novel strategies to prevent disease establishment and its progression.
A major shortcoming in the study of human African trypanosomiasis is the lack of suitable infection models that authentically mimic disease progression. In addition, the production of infectious metacyclic parasites requires tsetse flies, which are challenging to keep. Thus, although animal models - typically murine - have produced many insights into the pathogenicity of trypanosomes in the mammalian host, they were usually infected by needle injection into the peritoneal cavity or tail vein, bypassing the skin as the first entry point. Furthermore, animal models are not always predictive for the infection outcome in human patients. In addition, the relatively small number of metacyclic parasites deposited by the tsetse flies makes them difficult to trace, isolate, and study in animal hosts.
The focus of this thesis was to develop and validate a reconstructed human skin equivalent as an infection model to study the development of naturally-transmitted metacyclic parasites of T. brucei in mammalian skin. The first part of this work describes the development and characterization of a primary human skin equivalent with improved mechanical properties. To achieve this, a computer-assisted compression system was designed and established. This system allowed the improvement of the mechanical stability of twelve collagen-based dermal equivalents in parallel through plastic compression, as evaluated by rheology. The improved dermal equivalents provided the basis for the generation of the skin equivalents and reduced their contraction and weight loss during tissue formation, achieving a high degree of standardization and reproducibility. The skin equivalents were characterized using immunohistochemical and histological techniques and recapitulated key anatomical, cellular, and functional aspects of native human skin. Furthermore, their cellular heterogeneity was examined using single-cell RNA sequencing - an approach which led to the identification of a remarkable repertoire of extracellular matrix-associated genes expressed by different cell subpopulations in the artificial skin. In addition, experimental conditions were established to allow tsetse flies to naturally infect the skin equivalents with trypanosomes.
In the second part of the project, the development of the trypanosomes in the artificial skin was investigated in detail. This included the establishment of methods to successfully isolate skin-dwelling trypanosomes to determine their protein synthesis rate, cell cycle and metabolic status, morphology, and transcriptome. Microscopy techniques to study trypanosome motility and migration in the skin were also optimized. Upon deposition in the artificial skin by feeding tsetse, the metacyclic parasites were rapidly activated and established a proliferative population within one day. This process was accompanied by: (I) reactivation of protein synthesis; (II) re-entry into the cell cycle; (III) change in morphology; (IV) increased motility. Furthermore, these observations were linked to potentially underlying developmental mechanisms by applying single-cell parasite RNA sequencing at five different timepoints post-infection.
After the initial proliferative phase, the tsetse-transmitted trypanosomes appeared to enter a reversible quiescence program in the skin. These quiescent skin-residing trypanosomes were characterized by very slow replication, a strongly reduced metabolism, and a transcriptome markedly different from that of the deposited metacyclic forms and the early proliferative trypanosomes. By mimicking the migration from the skin to the bloodstream, the quiescent phenotype could be reversed and the parasites returned to an active proliferating state. Given that previous work has identified the skin as an anatomical reservoir for T. brucei during disease, it is reasonable to assume that the quiescence program is an authentic facet of the parasite's behavior in an infected host.
In summary, this work demonstrates that primary human skin equivalents offer a new and promising way to study vector-borne parasites under close-to-natural conditions as an alternative to animal experimentation. By choosing the natural transmission route - the bite of an infected tsetse fly - the early events of trypanosome infection have been detailed with unprecedented resolution. In addition, the evidence here for a quiescent, skin-residing trypanosome population may explain the persistence of T. brucei in the skin of aparasitemic and asymptomatic individuals. This could play an important role in maintaining an infection over long time periods. / Zahlreiche Arthropoden wie Stechmücken, Zecken, Wanzen und Fliegen sind Überträger für krankheitserregende Parasiten, Bakterien und Viren. Hierzu gehört der einzellige Parasit Trypanosoma brucei (T. brucei), welcher durch Tsetsefliegen übertragen wird und die Afrikanische Trypanosomiasis bei Menschen und Tieren verursacht. Der Entwicklungszyklus des Parasiten in der Fliege ist komplex und endet in der Speicheldrüse mit der Differenzierung in das metazyklische Lebensstadium. Diese metazyklischen Formen werden durch den Biss der blutsaugenden Tsetsefliege in die dermale Hautschicht des Säugetierwirts injiziert. Die zellzyklusarretierten metazyklischen Formen werden in der Dermis aktiviert und der Widereintritt in den Zellzyklus sowie die Differenzierung zu proliferativen Trypanosomen eingeleitet. Anschließend breitet sich der Parasit systemisch im Säugetierwirt aus.
Obwohl T. brucei bereits seit Jahrzehnten erforscht wird, ist nur sehr wenig über das frühe Infektionsgeschehen in der Haut bekannt. Der genaue Zeitpunkt und die Mechanismen, die der Differenzierung des Parasiten in der Haut zugrunde liegen, sind unbekannt. Ebenso wurden die proliferativen Trypanosomen in der Haut bisher nur unzureichend charakterisiert. Das Verständnis über die ersten Schritte einer Infektion ist jedoch von entscheidender Bedeutung für die Entwicklung von neuen Strategien, die die Krankheitsentstehung und deren Fortschreiten verhindern sollen.
Ein großes Hindernis bei der Erforschung der humanen Afrikanischen Trypanosomiasis ist der Mangel an geeigneten Infektionsmodellen, die den Krankheitsverlauf authentisch nachbilden. Außerdem werden für die Erzeugung der infektiösen metazyklischen Parasiten Tsetsefliegen benötigt, die aufwändig zu züchten sind. Tiermodelle haben es ermöglicht - hauptsächlich Mäuse -, viele Erkenntnisse über die Pathogenese von Trypanosomen im Säugetierwirt zu erlangen. Allerdings wurden diese überwiegend durch Nadelinjektion in den Bauchraum oder die Kaudalvene infiziert, wodurch die Haut als erste Eintrittspforte umgangen wurde. Darüber hinaus lassen Tiermodelle nicht immer Rückschlüsse auf den Infektionsverlauf beim Menschen zu. Zusätzlich erschwert die geringe Anzahl von metazyklischen Parasiten, die von Tsetsefliegen injiziert werden, die Isolation, Nachweis und Untersuchung im tierischen Wirt.
Das Ziel der vorliegenden Arbeit war es, ein rekonstruiertes menschliches Hautäquivalent zu entwickeln und als Infektionsmodell zu validieren, um die Entwicklung von natürlich übertragenen metazyklischen Parasiten von T. brucei in der Säugetierhaut zu untersuchen. Der erste Teil dieser Arbeit beschreibt die Entwicklung und Charakterisierung eines primären menschlichen Hautäquivalents mit verbesserten mechanischen Eigenschaften. Zu diesem Zweck wurde ein computergesteuertes Kompressionssystem entworfen und hergestellt. Dieses System ermöglichte die gleichzeitige Verbesserung der mechanischen Stabilität von zwölf kollagenbasierten dermalen Äquivalenten durch plastische Kompression, die mittels Rheologie evaluiert wurden. Die verbesserten dermalen Äquivalente dienten als Fundament für die Erzeugung der Hautäquivalente und reduzierten deren Kontraktion und Gewichtsverlust während der Gewebebildung. Dadurch wurde ein hohes Maß an Standardisierung und Reproduzierbarkeit erreicht. Die Hautäquivalente wurden durch immunhistochemische und histologische Techniken charakterisiert und bildeten wichtige anatomische, zelluläre und funktionelle Aspekte der nativen menschlichen Haut nach. Des Weiteren wurde die zelluläre Heterogenität durch Einzelzell-RNA-Sequenzierung untersucht. Mit dieser Technik wurde ein umfangreiches Spektrum an extrazellulären Matrix-assoziierten Genen identifiziert, die von verschiedenen Zellsubpopulationen in der künstlichen Haut exprimiert werden. Zusätzlich wurden experimentelle Bedingungen etabliert, damit Tsetsefliegen eingesetzt werden konnten, um die Hautäquivalente auf natürlichem Weg mit Trypanosomen zu infizieren.
Im zweiten Teil dieser Arbeit wurde die Entwicklung der Trypanosomen in der künstlichen Haut im Detail untersucht. Dies umfasste die Etablierung von Methoden zur erfolgreichen Isolierung der Trypanosomen aus der Haut, um deren Proteinsyntheserate, Zellzyklus- und Stoffwechselstatus, sowie Morphologie und Transkriptom zu bestimmen. Zusätzlich wurden Mikroskopietechniken zur Untersuchung der Trypanosomenmotilität und migration in der Haut optimiert. Nach der Injektion in die künstliche Haut durch Tsetsefliegen wurden die metazyklischen Parasiten schnell aktiviert und etablierten innerhalb eines Tages eine proliferative Population. Dieser Entwicklungsprozess wurde begleitet von (I) einer Reaktivierung der Proteinsynthese, (II) einem Wiedereintritt in den Zellzyklus, (III) einer Veränderung der Morphologie und (IV) einer erhöhten Motilität. Des Weiteren wurden diese Beobachtungen mit potentiell zugrundeliegenden entwicklungsbiologischen Mechanismen in Verbindung gebracht, indem eine Einzelzell RNA-Sequenzierung der Trypanosomen zu fünf verschiedenen Zeitpunkten nach der Infektion durchgeführt wurde.
Nach der ersten proliferativen Phase traten die Tsetse-übertragenen Trypanosomen in der Haut in ein reversibles Ruhestadium ein. Diese ruhenden Trypanosomen waren durch eine sehr langsame Zellteilung, einen stark reduzierten Stoffwechsel und ein Transkriptom gekennzeichnet, dass sich deutlich von dem der injizierten metazyklischen Formen und der ersten proliferativen Trypanosomen unterschied. Durch Nachahmung der Migration von der Haut in den Blutkreislauf konnte dieser Phänotyp reaktiviert werden und die Parasiten kehrten in einen aktiven, proliferierenden Zustand zurück. Unter Berücksichtigung, dass vorangegangene Forschungsarbeiten die Haut als anatomisches Reservoir für T. brucei während des Krankheitsverlaufs identifiziert haben, ist anzunehmen, dass das Ruheprogramm eine authentische Facette im Verhalten des Parasiten in einem infizierten Wirt darstellt.
Zusammenfassend zeigt diese Arbeit, das primäre menschliche Hautäquivalente eine neue und vielversprechende Möglichkeit bieten, vektorübertragene Parasiten unter naturnahen Bedingungen als Alternative zu Tierversuchen zu untersuchen. Durch die Verwendung des natürlichen Infektionsweges - dem Biss einer infizierten Tsetsefliege -, konnten die frühen Prozesse einer Trypanosomen-Infektion mit noch nie dagewesener Detailtiefe nachvollzogen werden. Des Weiteren könnte der hier erbrachte Nachweis einer ruhenden, hautresidenten Trypanosomen-Population die Persistenz von T. brucei in der Haut von aparasitämischen und asymptomatischen Personen erklären. Dies könnte eine wichtige Rolle bei der Aufrechterhaltung einer Infektion über lange Zeiträume spielen.
|
95 |
Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African Trypanosomiasis.Oluwafemi, A.J., Okanla, O., Camps, P., Muñoz-Torrero, D., Mackey, Z.B., Chiang, P.K., Seville, Scott, Wright, Colin W. January 2009 (has links)
No / The alkaloid cryptolepine (1) and eight synthetic analogues (2-8) were assessed for in vitro activities against Trypanosoma brucei. Four of the analogues were found to be highly potent with IC50 values of less than 3 nM and three of these were assessed against T. brucei brucei infection in rats. The most effective compound was 2,7-dibromocryptolepine (7); a single oral dose of 20 mg/Kg suppressed parasitaemia and increased the mean survival time to 13.6 days compared with 8.4 days for untreated controls. In addition, four huperzine derivatives (9-12) were shown to have in vitro antitrypanosomal activities with IC50 values from 303-377 nM.
|
96 |
Ethyl pyruvate emerges as a safe and fast acting agent against Trypanosoma brucei by targeting pyruvate kinase activityWorku, Netsanet, Stich, August, Daugschies, Arwid, Wenzel, Iris, Kurz, Randy, Thieme, Rene, Kurz, Susanne, Birkenmeier, Gerd 18 September 2015 (has links) (PDF)
Background: Human African Trypanosomiasis (HAT) also called sleeping sickness is an infectious disease in humans caused by an extracellular protozoan parasite. The disease, if left untreated, results in 100% mortality. Currently available drugs are full of severe drawbacks
and fail to escape the fast development of trypanosoma resistance. Due to similarities in cell metabolism between cancerous tumors and trypanosoma cells, some of the current registered drugs against HAT have also been tested in cancer chemotherapy. Here we demonstrate
for the first time that the simple ester, ethyl pyruvate, comprises such properties.
Results: The current study covers the efficacy and corresponding target evaluation of ethyl pyruvate on T. brucei cell lines using a combination of biochemical techniques including cell proliferation assays, enzyme kinetics, phasecontrast microscopic video imaging and ex vivo toxicity tests. We have shown that ethyl pyruvate effectively kills trypanosomes most probably by net ATP depletion through inhibition of pyruvate kinase (Ki = 3.0±0.29 mM). The potential of ethyl pyruvate as a trypanocidal compound is also strengthened by its fast acting property, killing cells within three hours post exposure. This has been demonstrated using video
imaging of live cells as well as concentration and time dependency experiments. Most importantly, ethyl pyruvate produces minimal side effects in human red cells and is known to easily cross the blood-brain-barrier. This makes it a promising candidate for effective treatment of the two clinical stages of sleeping sickness. Trypanosome drug-resistance tests indicate irreversible cell death and a low incidence of resistance development under experimental conditions.
Conclusion: Our results present ethyl pyruvate as a safe and fast acting trypanocidal compound and show that it inhibits the enzyme pyruvate kinase. Competitive inhibition of this enzyme was found to cause ATP depletion and cell death. Due to its ability to easily cross the bloodbrain-
barrier, ethyl pyruvate could be considered as new candidate agent to treat the hemolymphatic as well as neurological stages of sleeping sickness.
|
97 |
Nitroaromatic pro-drug activation and resistance in the African trypanosomeSokolova, Antoaneta Y. January 2011 (has links)
Sleeping sickness, caused by Trypanosoma brucei, is a deadly disease that affects some of the poorest countries in sub-Saharan Africa. Although the disease prevalence is declining, strengthening of the current control efforts, including introduction of more adequate chemotherapeutic options, is needed to prevent the re-emergence of yet another epidemic. Nitroaromatic compounds, such as nifurtimox (in combination with eflornithine) and fexinidazole (in clinical trials), have been recently introduced for the treatment of the second stage of sleeping sickness. These compounds are believed to act as pro-drugs that require intracellular enzymatic activation for antimicrobial activity. Here, the role of the bacterial-like nitroreductase TbNTR as a nitrodrug activating enzyme is examined through overexpression and knock-out studies in T. brucei. Multiple attempts to purify soluble recombinant TbNTR from E. coli were unsuccessful, because the recombinant protein was found to be membrane associated. In keeping with the role of TbNTR in nitrodrug activation, loss of an NTR gene copy in T. brucei was found to be one, but not the only, mechanism that may lead to nitrodrug resistance. Furthermore, in the bloodstream form of T. brucei, resistance was relatively easy to select for nifurtimox, with no concurrent loss of virulence and at clinically relevant levels. More worryingly, nifurtimox resistance led to a decreased sensitivity of these parasites to other nitroaromatic compounds, including a high level of cross-resistance to fexinidazole. Conversely, generation of fexinidazole resistance resulted in cross-resistance to nifurtimox. Should these findings translate to the field, emerging nitrodrug resistance could reverse all recent advances in the treatment of sleeping sickness, made since the introduction of eflornithine 20 years ago. Therefore, all efforts should be made to ensure nitroaromatic drugs are used only in drug combination therapies against sleeping sickness, in order to protect them from emerging resistance.
|
98 |
Ethyl pyruvate emerges as a safe and fast acting agent against Trypanosoma brucei by targeting pyruvate kinase activityWorku, Netsanet, Stich, August, Daugschies, Arwid, Wenzel, Iris, Kurz, Randy, Thieme, Rene, Kurz, Susanne, Birkenmeier, Gerd January 2015 (has links)
Background: Human African Trypanosomiasis (HAT) also called sleeping sickness is an infectious disease in humans caused by an extracellular protozoan parasite. The disease, if left untreated, results in 100% mortality. Currently available drugs are full of severe drawbacks
and fail to escape the fast development of trypanosoma resistance. Due to similarities in cell metabolism between cancerous tumors and trypanosoma cells, some of the current registered drugs against HAT have also been tested in cancer chemotherapy. Here we demonstrate
for the first time that the simple ester, ethyl pyruvate, comprises such properties.
Results: The current study covers the efficacy and corresponding target evaluation of ethyl pyruvate on T. brucei cell lines using a combination of biochemical techniques including cell proliferation assays, enzyme kinetics, phasecontrast microscopic video imaging and ex vivo toxicity tests. We have shown that ethyl pyruvate effectively kills trypanosomes most probably by net ATP depletion through inhibition of pyruvate kinase (Ki = 3.0±0.29 mM). The potential of ethyl pyruvate as a trypanocidal compound is also strengthened by its fast acting property, killing cells within three hours post exposure. This has been demonstrated using video
imaging of live cells as well as concentration and time dependency experiments. Most importantly, ethyl pyruvate produces minimal side effects in human red cells and is known to easily cross the blood-brain-barrier. This makes it a promising candidate for effective treatment of the two clinical stages of sleeping sickness. Trypanosome drug-resistance tests indicate irreversible cell death and a low incidence of resistance development under experimental conditions.
Conclusion: Our results present ethyl pyruvate as a safe and fast acting trypanocidal compound and show that it inhibits the enzyme pyruvate kinase. Competitive inhibition of this enzyme was found to cause ATP depletion and cell death. Due to its ability to easily cross the bloodbrain-
barrier, ethyl pyruvate could be considered as new candidate agent to treat the hemolymphatic as well as neurological stages of sleeping sickness.
|
99 |
Investigating the simultaneous effect of age and temperature on the population dynamics of female tsetse fliesElama Ameh, Josephine, Ochigbo, Josephine Elanma 12 1900 (has links)
Thesis (MSc)--Stellenbosch University, 2011. / ENGLISH ABSTRACT: Age and temperature are two factors that affect mortality in adult tsetse flies. Both are found
to be very important, but the simultaneous effect of these factors on the mortality rate have
not been studied. This study seeks to address this, with an application to a population of
female tsetse, using a model based on partial differential equations. Adult mortality is agedependent
and is modelled as the sum of two exponentials, with four parameters (coefficients
of each exponential): numerical analysis of a population model with this mortality structure
predicts exponential growth. Analysis of each of the parameters through parameter variation
shows that two of these parameters control the mortality of the nulliparous (ages 0 − 10
days) flies only while the other two only take care of flies of mature ages. Measurement of
the impact of these parameters on the mortality of tsetse of different ages by the normalized
forward sensitivity index method is also carried out. This is followed by fitting the model
based on the age-dependent mortality along with a constant tsetse birth rate to data representing
the catches of female Glossina pallidipes at Rekomitjie Research station, Zimbabwe.
Considering a three parameter adult tsetse mortality, parameter analysis shows the effect of
one of the parameters to affect the mortality of flies of all ages while a second controls only the
mature tsetse flies of reproductive ages. A further analysis resulted in the estimate of these
parameters as functions of temperature, thereby leading to the establishment of an age and
temperature-dependent adult tsetse mortality. Using data for the daily average temperature
records obtained in 1981 on Antelope Island, Lake Kariba, Zimbabwe, daily changes in the
pupal duration (adult tsetse birth rate) changes negatively with temperature change. Incorporating
this (temperature-dependent ) birth rate into the model, together with the established
age and temperature-dependent adult mortality, the adult tsetse population dynamics is explored
numerically. The latter model is then fitted to population data of female Glossina
morsitans morsitans obtained from the same Island and for the same period as used for
the temperature data. The data suggests peak tsetse population to be in the month of July
and lowest in the month of December. The first quarter of the year is predicted to be most
favorable for breeding tsetse while the second, showed a period of stable growth rate and a
time of tsetse abundance. In addition, the dynamics with both age and temperature showed a
non-uniform daily population growth contrary to that with age effect only. This study has enhanced
our understanding of tsetse population dynamics for age and temperature-dependent
adult mortality with temperature-dependent pupal duration and suggests the period of tsetse
abundance on Antelope Island. / AFRIKAANSE OPSOMMING: Geen opsomming in Afrikaans.
|
100 |
TbISWI and its role in transcriptional control in Trypanosoma bruceiKushwaha, Manish January 2010 (has links)
ISWI is a member of a versatile family of ATP-dependent chromatin remodelling complexes involved not only in transcription regulation (initiation, elongation and termination), but also in other cellular functions like maintenance of higher order chromatin structure and DNA replication. TbISWI, a novel ATPase of the ISWI family in Trypanosoma brucei, is involved in the transcriptional repression of silent VSG expression sites (ESs) in both bloodstream form (BF) and procyclic form (PF) life cycle stages of the parasite. Using in silico analysis, I have found that TbISWI is well conserved across the eukaryotic lineage, including those members of the order Kinetoplastida that do not exhibit antigenic variation. Compared to the ISWIs of higher eukaryotes, TbISWI has greater representation of random coils within its structure, an indicator of more structural fluidity and flexibility of interaction with multiple protein partners. Using an eGFP reporter based assay, I have studied the role of TbISWI in transcriptional repression of silent areas of the T. brucei genome. TbISWI was found to be involved in preventing inappropriate transcription of the silent VSG repertoires. TbISWI was also found to downregulate transcription in RNA pol I, but not pol II, transcription units. These results argue for the presence of at least two functionally distinct TbISWI complexes in T. brucei. Using DNA staining and fluorescence in situ hybridisation (FISH), I have investigated the potential effect of TbISWI depletion on cell cycle progression and minichromosome segregation. I did not find any evidence for the role of TbISWI in the maintenance of centromeric heterochromatin in T. brucei.
|
Page generated in 0.0675 seconds